Expression of chemokine receptors in the different clinical forms of multiple sclerosis

E M Martínez-Cáceres1, C Espejo, L Brieva

  • 1Unitat de Neuroimmunologia Clínica, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|October 3, 2002
PubMed

Insights

Chemokines and their receptors are implicated in multiple sclerosis (MS) pathogenesis. While elevated chemokine receptor expression was found in MS patients, distinct patterns for each clinical form were not observed.

Area of Science:

  • Neuroimmunology
  • Immunology
  • Cellular Biology

Background:

  • Chemokines and their receptors mediate leukocyte trafficking to the central nervous system, a key process in multiple sclerosis (MS) pathogenesis.
  • Distinct clinical forms of MS (relapsing-remitting, secondary progressive, and primary progressive) suggest potential differences in underlying pathogenic mechanisms.

Purpose of the Study:

  • To investigate potential differences in chemokine receptor expression between various clinical forms of MS.
  • To compare the membrane expression of CC and CXC chemokine receptors (CCR1, CCR5, CXCR3, CXCR4) in peripheral blood cells of MS patients and healthy controls.

Main Methods:

  • Flow cytometry was used to analyze the surface expression of chemokine receptors (CCR5, CXCR3, CXCR4) on peripheral blood cells (CD4+, CD8+, CD19+, CD14+).
  • Levels of CXCL10 (IP-10) and CCL5 (RANTES) were measured in the cerebrospinal fluid of a subgroup of MS patients.

Main Results:

  • MS patients exhibited significantly increased surface expression of CCR5 on CD4+, CD8+, CD19+, and CD14+ cells compared to healthy controls.
  • An increased percentage of CXCR3 and CXCR4 was observed on CD14+ cells in MS patients.
  • Elevated levels of CXCL10 and CCL5 were detected in the cerebrospinal fluid of some MS patients.

Conclusions:

  • Chemokines and their receptors play a role in the pathogenesis of multiple sclerosis.
  • Despite observed differences in chemokine receptor expression in MS patients, no specific pattern was identified that characterizes each distinct clinical form of the disease.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...